TMO - Abcam ticks higher as founder Milner says Danaher deal undervalues company
2023-09-01 10:13:53 ET
More on Abcam ADS
- Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold
- Abcam: Nosebleed Valuations, Flat Growth Profile Justify Hold Rating
- Abcam cut to market perform at Leerink, sees no antitrust risk
- Abcam deal price may have been hurt by antitrust concerns - report (update)
- Seeking Alpha’s Quant Rating on Abcam ADS
- Earnings data for Abcam ADS
For further details see:
Abcam ticks higher as founder Milner says Danaher deal undervalues company